News:Research and scientific results

This study suggests that certain stressful life events can impact brain health differently depending on gender and educational level

This fully automated blood test could become a scalable, minimally invasive tool to detect and monitor Alzheimer’s-related changes long before symptoms appear.

The study, published in the journal Alzheimer’s & Dementia, involved 337 people from the ALFA longitudinal cohort of the Barcelonaβeta Brain Research Center (BBRC), with the support of the “la Caixa” Foundation.

A study involving more than 1,700 people from five hospitals in Barcelona, Sweden and Italy has validated the usefulness of a biomarker in blood to detect Alzheimer's disease in the clinical setting.

The study highlights the need to adapt recruitment strategies to existing gender differences to ensure equitable representation in research.

The findings revealed that plasma p-tau biomarkers demonstrated superior accuracy in detecting Alzheimer’s compared to other biomarkers

The work, led by the BBRC and published in Alzheimer’s & Dementia, has been pivotal in securing the European Medicines Agency's approval of the Centiloid metric as a valid biomarker for Alzheimer’s disease.

The results are compiled in a study published in iScience, led by the Hospital del Mar Medical Research Institute and the Barcelonaβeta Brain Research Center, center of the Pasqual Maragall Foundation.

The data have been compared with Alzheimer's biomarkers of 2,300 people from four cohorts, including participants without cognitive alterations from the ALFA Study, promoted by the ”la Caixa” Foundation.